Delivers up-to-date industry news on topics like drug approvals, product recalls, company expansions and acquisitions, market trends for all OSD forms, as well as excipients, packaging and supply chain issues. Monitors market trends in specific drug categories as well as in supplements/nutraceuticals. Provides updates on clinical trials. Includes alerts about new or upcoming regulatory issues.
Almac Sciences, a member of the Almac Group, has been awarded a Life Sciences Innovative Manufacturing Fund (LSIMF) Grant to support the expansion of its small molecule active pharmaceutical ingredients (API) manufacturing facility at its Global Headquarters in Craigavon, UK.
read more
Xcovery Holdings, Inc., announced that the FDA accepted the New Drug Application (NDA) for ensartinib, an Anaplastic Lymphoma Kinase (ALK) inhibitor for the treatment of adult patients with metastatic ALK-positive non-small cell lung cancer (NSCLC).
read more
IFM Therapeutics (IFM), a privately held biopharmaceutical company focused on developing therapies that modulate novel targets in the innate immune system, announced that Novartis has exercised its option to acquire all of the outstanding capital stock of IFM Due, a subsidiary company of IFM.
read more
Adare Pharma Solutions announced it is further investing in its Pessano facility in Milan, Italy, with the addition of a high-shear mixer granulator to complement existing fluid bed capabilities. This addition follows the recently announced expansion of blister packaging and warehousing capabilities at the site.
read more
The U.S. FDA announced it is requesting $7.2 billion as part of the President's fiscal year (FY) 2025 proposed budget.
read more
CAPTEK® Softgel International, a contract manufacturer of dietary supplements has officially begun gummy supplement production in La Mirada, California.
read more
Journey Medical Corporation announced that data from the Phase 1 clinical trial (DFD-29-CD-006) assessing the impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on the microbial flora of healthy adults were presented at the 2024 American Academy of Dermatology (AAD)
read more
OncoZenge AB (publ), a pharmaceutical company dedicated to the development of solutions for oral pain relief, today announces that Eurosin Capital AB has been retained as advisors to explore strategic options for the introduction of BupiZenge™ in China.
read more
Travere Therapeutics, Inc. announced the submission of a supplemental New Drug Application (sNDA) to the FDA for conversion of the existing U.S. accelerated approval of FILSPARI® (sparsentan) in IgA nephropathy (IgAN) to full approval.
read more
According to Straits Research, “The global softgel capsules market size was valued at USD 7.55 billion in 2021. It is projected to reach USD 14.86 billion by 2030, growing at a CAGR of 7.81% during the forecast period (2022–2030).”
read more
Bristol Myers Squibb recently announced that the FDA accepted for priority review the supplemental new drug application (sNDA) for KRAZATI® (adagrasib) in combination with cetuximab for the treatment of patients with previously treated KRASG12C-mutated locally advanced or metastatic colorectal cancer (CRC).
read more
Gilead Sciences and Merck announced results from the Phase 2 clinical study evaluating the investigational combination of islatravir, an investigational nucleoside reverse transcriptase translocation inhibitor, and lenacapavir, a first-in-class capsid inhibitor.
read more
Adare Pharma Solutions, a CDMO focused on oral dosage forms, announced that work has begun to add packaging capabilities and further warehousing capacity at its Pessano facility in Milan, Italy.
read more
Perrigo Company announced that Opill® has shipped to major retailers and pharmacies and will be available on shelves nationwide and online later this month. Approved by the FDA for OTC use for all ages in July 2023, Opill® is the first-ever daily birth control pill available without a prescription in the U.S.
read more
KORSCH America, a provider of tablet press technology offering solutions for product development, scale-up, high-speed production, multi-layer, mini-tablet, and WIP/high-containment applications, opened an INNOVATION CENTER at its headquarters facility in the Boston suburb of South Easton, MA.
read more